
|Articles|March 1, 1998
The American Journal of Managed Care
- March 1998
- Volume 4
- Issue 3
A Cost-Effectiveness Clinical Decision Analysis Model for Schizophrenia
Advertisement
Articles in this issue
over 27 years ago
Treatment of Schizophrenia: Let's Talk Dollars and Senseover 27 years ago
Maintaining Skeletal Health Among Postmenopausal Womenover 27 years ago
Work-up for Diverticulitisover 27 years ago
Screening and Surveillance for Colorectal CancerNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
2
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
3
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
4
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
5














































